Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Comparative Evaluation of Anti-Angiogenic Effects of Biosimilar Drugs in a DL-α-Aminoadipic Acid Rabbit Model of Chronic Vascular Leakage in Retina.

Donatas Neverauskas; Robertas Cesna; Symantas Ragauskas; Tomas Paulauskas; Giedrius Kalesnykas; Jeffrey Adam Jamison; Odeta Adamoniene

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):712.

ARVO Annual Meeting Abstract June 2024

Title: Bacterial Cell Wall Component Induced Uveitis in Brown Norway Rats

Austin Brown; Marianna Bacellar-Galdino; Nate Pappenhagen; Juliette Arnold; Binnie Thomas; Jeffrey Adam Jamison

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5614.

ARVO Annual Meeting Abstract June 2023

Abnormalities in the electroretinogram of a rat genetic model of Fragile X syndrome

Jeffrey Adam Jamison; Marianna Bacellar-Galdino; Olivier perche; robert ring

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):5219.

ARVO Annual Meeting Abstract June 2023

Efficacy of topical ketotifen and prednisolone in the rabbit 48/80 model for allergic conjunctivitis

Nate Edward Pappenhagen; Sana Iqbal; Simon Kaja; Jeffrey Adam Jamison; Marianna Bacellar-Galdino

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3548.

ARVO Annual Meeting Abstract June 2022

Efficacy of tandospirone and cytokine production in the mouse blue light damage model of dry AMD.

Jeffrey Adam Jamison; Anita Kirti Ghosh; Sean David Ogle; Nathaniel Edward Pappenhagen; Marianna Bacellar-Galdino; Simon Kaja

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4597 – F0389.

ARVO Annual Meeting Abstract June 2021

Anti-Inflammatory and Protective Effects of Topical Ophthalmic (R)-DOI 0.01% in Allergic Conjunctivitis and Recurrent Intermediate Uveitis Disease Models in Rabbits.

EMELINE MAILLET; Daniel Skutnik; Jeffrey Adam Jamison; David Bailey; Marianna Bacellar-Galdino; David Garlick

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):232.

ARVO Annual Meeting Abstract June 2020

Light and Dark discrimination testing in Gnb3 -/- rats

Marianna Bacellar-Galdino; John Rozofsky; Simon M Petersen-Jones; Jeffrey Adam Jamison

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4280.

ARVO Annual Meeting Abstract July 2018

New device to measure behavioral vision in rodents

Marianna Bacellar-Galdino; Jeffrey Adam Jamison

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5525.

ARVO Annual Meeting Abstract June 2017

Validation and characterization of a chronic model of retinal leakage in the Dutch Belted Rabbit using DL-AAA

Jeffrey Adam Jamison

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1993.

ARVO Annual Meeting Abstract June 2017

Rabbit Safety of Topical PPL-003: A Cell-Penetrating Peptide Inhibitor of NFkB for Dry Eye Disease

Bruce H. Littman; Jeffrey Adam Jamison; Ricardo Ochoa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):460.

ARVO Annual Meeting Abstract September 2016

Efficacy of PPL-003 and Inhibition of NFκB Activation in a Rabbit Mycobacterial Antigen-Induced Uveitis Model

James T Rosenbaum; Bruce H. Littman; Frank W Marcoux; Jeffrey Adam Jamison

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1896.

ARVO Annual Meeting Abstract September 2016

Efficacy of PPL-003 and the Role of NFκB Activation in a Rat Model of Dry Eye Disease

Bruce H. Littman; Frank W Marcoux; Jeffrey Adam Jamison

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):407.

Advertisement